Predictive Technology Group Inc banner

Predictive Technology Group Inc
OTC:PRED

Watchlist Manager
Predictive Technology Group Inc Logo
Predictive Technology Group Inc
OTC:PRED
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: $30k

Relative Value

PRED doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of PRED.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PRED Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Multiples Across Competitors

PRED Competitors Multiples
Predictive Technology Group Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Predictive Technology Group Inc
OTC:PRED
30k USD 0 -0 -0.2 -0.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 643 258.8 -159 901.4 -194 171.3 -191 955.6
US
Abbvie Inc
NYSE:ABBV
409.8B USD 6.9 174.4 16.8 23.9
US
Amgen Inc
NASDAQ:AMGN
198.7B USD 5.4 25.8 14.8 14.8
US
Gilead Sciences Inc
NASDAQ:GILD
193.1B USD 6.6 23.8 16.2 16.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
124.5B USD 10.6 33.9 25 26.1
US
Epizyme Inc
F:EPE
94.1B EUR 2 094 -534.3 -581.8 -566.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
84.3B USD 5.9 18.7 14.2 16.2
AU
CSL Ltd
ASX:CSL
72.6B AUD 3.2 16.8 11.5 14.4
NL
argenx SE
XBRU:ARGX
43.1B EUR 14.4 33.9 57.9 59.5
US
Seagen Inc
F:SGT
39.3B EUR 20.2 -61.8 -66.7 -60.2
P/S Multiple
Revenue Growth P/S to Growth
US
Predictive Technology Group Inc
OTC:PRED
Average P/S: 3 058 675.1
0
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
33 643 258.8
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.9
9%
0.8
US
Amgen Inc
NASDAQ:AMGN
5.4
2%
2.7
US
Gilead Sciences Inc
NASDAQ:GILD
6.6
4%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.6
10%
1.1
US
E
Epizyme Inc
F:EPE
2 094
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.9
9%
0.7
AU
CSL Ltd
ASX:CSL
3.2
5%
0.6
NL
argenx SE
XBRU:ARGX
14.4
49%
0.3
US
S
Seagen Inc
F:SGT
20.2
30%
0.7
P/E Multiple
Earnings Growth PEG
US
Predictive Technology Group Inc
OTC:PRED
Average P/E: 46.8
Negative Multiple: -0
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -159 901.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
174.4
89%
2
US
Amgen Inc
NASDAQ:AMGN
25.8
18%
1.4
US
Gilead Sciences Inc
NASDAQ:GILD
23.8
192%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
33.9
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -534.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.7
13%
1.4
AU
CSL Ltd
ASX:CSL
16.8
11%
1.5
NL
argenx SE
XBRU:ARGX
33.9
42%
0.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Predictive Technology Group Inc
OTC:PRED
Average EV/EBITDA: 22.3
Negative Multiple: -0.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 171.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.8
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.8
10%
1.5
US
Gilead Sciences Inc
NASDAQ:GILD
16.2
7%
2.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25
16%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -581.8 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.2
23%
0.6
AU
CSL Ltd
ASX:CSL
11.5
8%
1.4
NL
argenx SE
XBRU:ARGX
57.9
810%
0.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.7 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Predictive Technology Group Inc
OTC:PRED
Average EV/EBIT: 24.4
Negative Multiple: -0.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -191 955.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.9
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
14.8
2%
7.4
US
Gilead Sciences Inc
NASDAQ:GILD
16.2
13%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.1
16%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -566.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
21%
0.8
AU
CSL Ltd
ASX:CSL
14.4
11%
1.3
NL
argenx SE
XBRU:ARGX
59.5
N/A N/A
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.2 N/A N/A